Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP

Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2006-06, Vol.16 (12), p.3175-3179
Hauptverfasser: COX, Christopher D, TORRENT, Maricel, LOBELL, Robert B, WEIKANG TAO, SOUTH, Vicki J, KOHL, Nancy E, YOUWEI YAN, KUO, Lawrence C, PRUEKSARITANONT, Thomayant, SLAUGHTER, Donald E, CHUNZE LI, MAHAN, Elizabeth, BRESLIN, Michael J, BING LU, HARTMAN, George D, MARIANO, Brenda J, WHITMAN, David B, COLEMAN, Paul J, BUSER, Carolyn A, WALSH, Eileen S, HAMILTON, Kelly, SCHABER, Michael D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3179
container_issue 12
container_start_page 3175
container_title Bioorganic & medicinal chemistry letters
container_volume 16
creator COX, Christopher D
TORRENT, Maricel
LOBELL, Robert B
WEIKANG TAO
SOUTH, Vicki J
KOHL, Nancy E
YOUWEI YAN
KUO, Lawrence C
PRUEKSARITANONT, Thomayant
SLAUGHTER, Donald E
CHUNZE LI
MAHAN, Elizabeth
BRESLIN, Michael J
BING LU
HARTMAN, George D
MARIANO, Brenda J
WHITMAN, David B
COLEMAN, Paul J
BUSER, Carolyn A
WALSH, Eileen S
HAMILTON, Kelly
SCHABER, Michael D
description Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.
doi_str_mv 10.1016/j.bmcl.2006.03.040
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67938098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67938098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</originalsourceid><addsrcrecordid>eNqFUctqFTEYDqLY0-oLuJBslArN-GeSycy4k-KNFixUwV1IMhlPTjOXJhnk-GK-njl24CxdJR98N_4PoRcUCgpUvN0VejC-KAFEAawADo_QhnLBCeNQPUYbaAWQpuU_TtBpjDsAyoHzp-iECgGMVWKD_ly50UY34ji7sfMWz2FKNuPzq9ubN9iNW6ddmkIs8I0KCfN3-DaFxaQlWKJVtB3usv7niKceV0T5u71Xgxsnwi4q0jkV9p7wf9_tvgvTvA_q9-RtxCriOUeN6QL_UskGEie_6NzgmHnwTFuLh4ySM_hu7ZqrPUNPeuWjfb6-Z-j7xw_fLj-T66-fvly-vyaGl00ipbCq0hxAK860AdNVPVN1b63lilVt2auyyxha3VMlyroySjNuRN0bZkvLztDrB998l_vFxiQHF431Xo12WqIUdcsaaJv_EmlNRVPXVSaWD0QTphiD7eUc3JDvJCnIw65yJw-7ysOuEpjMu2bRy9V90YPtjpJ1yEx4tRJUNMr3QY3GxSMvJzeNqNlfEgev3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17168775</pqid></control><display><type>article</type><title>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>COX, Christopher D ; TORRENT, Maricel ; LOBELL, Robert B ; WEIKANG TAO ; SOUTH, Vicki J ; KOHL, Nancy E ; YOUWEI YAN ; KUO, Lawrence C ; PRUEKSARITANONT, Thomayant ; SLAUGHTER, Donald E ; CHUNZE LI ; MAHAN, Elizabeth ; BRESLIN, Michael J ; BING LU ; HARTMAN, George D ; MARIANO, Brenda J ; WHITMAN, David B ; COLEMAN, Paul J ; BUSER, Carolyn A ; WALSH, Eileen S ; HAMILTON, Kelly ; SCHABER, Michael D</creator><creatorcontrib>COX, Christopher D ; TORRENT, Maricel ; LOBELL, Robert B ; WEIKANG TAO ; SOUTH, Vicki J ; KOHL, Nancy E ; YOUWEI YAN ; KUO, Lawrence C ; PRUEKSARITANONT, Thomayant ; SLAUGHTER, Donald E ; CHUNZE LI ; MAHAN, Elizabeth ; BRESLIN, Michael J ; BING LU ; HARTMAN, George D ; MARIANO, Brenda J ; WHITMAN, David B ; COLEMAN, Paul J ; BUSER, Carolyn A ; WALSH, Eileen S ; HAMILTON, Kelly ; SCHABER, Michael D</creatorcontrib><description>Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2006.03.040</identifier><identifier>PMID: 16603356</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Alkylation ; Allosteric Site ; Amination ; Animals ; Antineoplastic agents ; Biological and medical sciences ; Crystallography, X-Ray ; Dogs ; Drug Design ; General aspects ; Hydroxylation ; Kinesin - antagonists &amp; inhibitors ; Kinesin - chemistry ; Kinesin - metabolism ; Medical sciences ; Mitosis ; Models, Molecular ; Molecular Structure ; Pharmacology. Drug treatments ; Pyrazoles - chemical synthesis ; Pyrazoles - chemistry ; Pyrazoles - pharmacokinetics ; Pyrazoles - pharmacology ; Solubility ; Structure-Activity Relationship ; Water</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2006-06, Vol.16 (12), p.3175-3179</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</citedby><cites>FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17758867$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16603356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>COX, Christopher D</creatorcontrib><creatorcontrib>TORRENT, Maricel</creatorcontrib><creatorcontrib>LOBELL, Robert B</creatorcontrib><creatorcontrib>WEIKANG TAO</creatorcontrib><creatorcontrib>SOUTH, Vicki J</creatorcontrib><creatorcontrib>KOHL, Nancy E</creatorcontrib><creatorcontrib>YOUWEI YAN</creatorcontrib><creatorcontrib>KUO, Lawrence C</creatorcontrib><creatorcontrib>PRUEKSARITANONT, Thomayant</creatorcontrib><creatorcontrib>SLAUGHTER, Donald E</creatorcontrib><creatorcontrib>CHUNZE LI</creatorcontrib><creatorcontrib>MAHAN, Elizabeth</creatorcontrib><creatorcontrib>BRESLIN, Michael J</creatorcontrib><creatorcontrib>BING LU</creatorcontrib><creatorcontrib>HARTMAN, George D</creatorcontrib><creatorcontrib>MARIANO, Brenda J</creatorcontrib><creatorcontrib>WHITMAN, David B</creatorcontrib><creatorcontrib>COLEMAN, Paul J</creatorcontrib><creatorcontrib>BUSER, Carolyn A</creatorcontrib><creatorcontrib>WALSH, Eileen S</creatorcontrib><creatorcontrib>HAMILTON, Kelly</creatorcontrib><creatorcontrib>SCHABER, Michael D</creatorcontrib><title>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.</description><subject>Alkylation</subject><subject>Allosteric Site</subject><subject>Amination</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Crystallography, X-Ray</subject><subject>Dogs</subject><subject>Drug Design</subject><subject>General aspects</subject><subject>Hydroxylation</subject><subject>Kinesin - antagonists &amp; inhibitors</subject><subject>Kinesin - chemistry</subject><subject>Kinesin - metabolism</subject><subject>Medical sciences</subject><subject>Mitosis</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrazoles - chemical synthesis</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrazoles - pharmacokinetics</subject><subject>Pyrazoles - pharmacology</subject><subject>Solubility</subject><subject>Structure-Activity Relationship</subject><subject>Water</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUctqFTEYDqLY0-oLuJBslArN-GeSycy4k-KNFixUwV1IMhlPTjOXJhnk-GK-njl24CxdJR98N_4PoRcUCgpUvN0VejC-KAFEAawADo_QhnLBCeNQPUYbaAWQpuU_TtBpjDsAyoHzp-iECgGMVWKD_ly50UY34ji7sfMWz2FKNuPzq9ubN9iNW6ddmkIs8I0KCfN3-DaFxaQlWKJVtB3usv7niKceV0T5u71Xgxsnwi4q0jkV9p7wf9_tvgvTvA_q9-RtxCriOUeN6QL_UskGEie_6NzgmHnwTFuLh4ySM_hu7ZqrPUNPeuWjfb6-Z-j7xw_fLj-T66-fvly-vyaGl00ipbCq0hxAK860AdNVPVN1b63lilVt2auyyxha3VMlyroySjNuRN0bZkvLztDrB998l_vFxiQHF431Xo12WqIUdcsaaJv_EmlNRVPXVSaWD0QTphiD7eUc3JDvJCnIw65yJw-7ysOuEpjMu2bRy9V90YPtjpJ1yEx4tRJUNMr3QY3GxSMvJzeNqNlfEgev3A</recordid><startdate>20060615</startdate><enddate>20060615</enddate><creator>COX, Christopher D</creator><creator>TORRENT, Maricel</creator><creator>LOBELL, Robert B</creator><creator>WEIKANG TAO</creator><creator>SOUTH, Vicki J</creator><creator>KOHL, Nancy E</creator><creator>YOUWEI YAN</creator><creator>KUO, Lawrence C</creator><creator>PRUEKSARITANONT, Thomayant</creator><creator>SLAUGHTER, Donald E</creator><creator>CHUNZE LI</creator><creator>MAHAN, Elizabeth</creator><creator>BRESLIN, Michael J</creator><creator>BING LU</creator><creator>HARTMAN, George D</creator><creator>MARIANO, Brenda J</creator><creator>WHITMAN, David B</creator><creator>COLEMAN, Paul J</creator><creator>BUSER, Carolyn A</creator><creator>WALSH, Eileen S</creator><creator>HAMILTON, Kelly</creator><creator>SCHABER, Michael D</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20060615</creationdate><title>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</title><author>COX, Christopher D ; TORRENT, Maricel ; LOBELL, Robert B ; WEIKANG TAO ; SOUTH, Vicki J ; KOHL, Nancy E ; YOUWEI YAN ; KUO, Lawrence C ; PRUEKSARITANONT, Thomayant ; SLAUGHTER, Donald E ; CHUNZE LI ; MAHAN, Elizabeth ; BRESLIN, Michael J ; BING LU ; HARTMAN, George D ; MARIANO, Brenda J ; WHITMAN, David B ; COLEMAN, Paul J ; BUSER, Carolyn A ; WALSH, Eileen S ; HAMILTON, Kelly ; SCHABER, Michael D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-26ea5b400ba43bc0cd5f3a7feee4a3592fa2da7f09bf1a6275cab34c67fc3e2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alkylation</topic><topic>Allosteric Site</topic><topic>Amination</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Crystallography, X-Ray</topic><topic>Dogs</topic><topic>Drug Design</topic><topic>General aspects</topic><topic>Hydroxylation</topic><topic>Kinesin - antagonists &amp; inhibitors</topic><topic>Kinesin - chemistry</topic><topic>Kinesin - metabolism</topic><topic>Medical sciences</topic><topic>Mitosis</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrazoles - chemical synthesis</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrazoles - pharmacokinetics</topic><topic>Pyrazoles - pharmacology</topic><topic>Solubility</topic><topic>Structure-Activity Relationship</topic><topic>Water</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>COX, Christopher D</creatorcontrib><creatorcontrib>TORRENT, Maricel</creatorcontrib><creatorcontrib>LOBELL, Robert B</creatorcontrib><creatorcontrib>WEIKANG TAO</creatorcontrib><creatorcontrib>SOUTH, Vicki J</creatorcontrib><creatorcontrib>KOHL, Nancy E</creatorcontrib><creatorcontrib>YOUWEI YAN</creatorcontrib><creatorcontrib>KUO, Lawrence C</creatorcontrib><creatorcontrib>PRUEKSARITANONT, Thomayant</creatorcontrib><creatorcontrib>SLAUGHTER, Donald E</creatorcontrib><creatorcontrib>CHUNZE LI</creatorcontrib><creatorcontrib>MAHAN, Elizabeth</creatorcontrib><creatorcontrib>BRESLIN, Michael J</creatorcontrib><creatorcontrib>BING LU</creatorcontrib><creatorcontrib>HARTMAN, George D</creatorcontrib><creatorcontrib>MARIANO, Brenda J</creatorcontrib><creatorcontrib>WHITMAN, David B</creatorcontrib><creatorcontrib>COLEMAN, Paul J</creatorcontrib><creatorcontrib>BUSER, Carolyn A</creatorcontrib><creatorcontrib>WALSH, Eileen S</creatorcontrib><creatorcontrib>HAMILTON, Kelly</creatorcontrib><creatorcontrib>SCHABER, Michael D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>COX, Christopher D</au><au>TORRENT, Maricel</au><au>LOBELL, Robert B</au><au>WEIKANG TAO</au><au>SOUTH, Vicki J</au><au>KOHL, Nancy E</au><au>YOUWEI YAN</au><au>KUO, Lawrence C</au><au>PRUEKSARITANONT, Thomayant</au><au>SLAUGHTER, Donald E</au><au>CHUNZE LI</au><au>MAHAN, Elizabeth</au><au>BRESLIN, Michael J</au><au>BING LU</au><au>HARTMAN, George D</au><au>MARIANO, Brenda J</au><au>WHITMAN, David B</au><au>COLEMAN, Paul J</au><au>BUSER, Carolyn A</au><au>WALSH, Eileen S</au><au>HAMILTON, Kelly</au><au>SCHABER, Michael D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2006-06-15</date><risdate>2006</risdate><volume>16</volume><issue>12</issue><spage>3175</spage><epage>3179</epage><pages>3175-3179</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>16603356</pmid><doi>10.1016/j.bmcl.2006.03.040</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (12), p.3175-3179
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_67938098
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alkylation
Allosteric Site
Amination
Animals
Antineoplastic agents
Biological and medical sciences
Crystallography, X-Ray
Dogs
Drug Design
General aspects
Hydroxylation
Kinesin - antagonists & inhibitors
Kinesin - chemistry
Kinesin - metabolism
Medical sciences
Mitosis
Models, Molecular
Molecular Structure
Pharmacology. Drug treatments
Pyrazoles - chemical synthesis
Pyrazoles - chemistry
Pyrazoles - pharmacokinetics
Pyrazoles - pharmacology
Solubility
Structure-Activity Relationship
Water
title Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A41%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinesin%20spindle%20protein%20(KSP)%20inhibitors.%20Part%204:%20Structure-based%20design%20of%205-alkylamino-3,5-diaryl-4,5-dihydropyrazoles%20as%20potent,%20water-soluble%20inhibitors%20of%20the%20mitotic%20kinesin%20KSP&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=COX,%20Christopher%20D&rft.date=2006-06-15&rft.volume=16&rft.issue=12&rft.spage=3175&rft.epage=3179&rft.pages=3175-3179&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2006.03.040&rft_dat=%3Cproquest_cross%3E67938098%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17168775&rft_id=info:pmid/16603356&rfr_iscdi=true